Angiotensin II-induced down-regulation of inositol trisphosphate receptors in WB rat liver epithelial cells. Evidence for involvement of the proteasome pathway

J Biol Chem. 1997 May 9;272(19):12454-61. doi: 10.1074/jbc.272.19.12454.

Abstract

Chronic stimulation of WB rat liver epithelial cells by angiotensin II (Ang II) resulted in the down-regulation of both type I and type III myo-inositol 1,4,5-trisphosphate receptors (IP3Rs). Stimulation with vasopressin, bradykinin, epidermal growth factor, or 12-O-tetradecanoylphorbol-13-acetate was without effect. Ang II-induced down-regulation of IP3Rs could be detected within 2 h and resulted in an inhibition of IP3-induced Ca2+ release from permeabilized cells. IP3R down-regulation was reversible, and both homo- and heterooligomers of IP3Rs were equally susceptible to Ang II-induced degradation. Chloroquine and NH4Cl increased the basal levels of IP3Rs by 2-fold, suggesting that the basal turnover of IP3Rs occurs via a lysosomal pathway. However, Ang II-induced degradation of IP3R was not affected by these inhibitors, suggesting that stimulated degradation of IP3Rs occurs via a non-lysosomal pathway. The cysteine protease and proteasomal inhibitor N-acetyl-Leu-Leu-norleucinal completely prevented Ang II-mediated down-regulation of IP3Rs, whereas the structural analog N-acetyl-Leu-Leu-methioninal was without effect. Lactacystin, a highly specific proteasome inhibitor, also blocked Ang II-mediated IP3R degradation. Stimulation with Ang II increased the amount of IP3R immunoprecipitated by anti-ubiquitin antibodies. We conclude that Ang II-stimulated IP3R degradation involves enhanced ubiquitination of the protein and degradation by the proteasome pathway.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylcysteine / analogs & derivatives
  • Acetylcysteine / pharmacology
  • Angiotensin II / pharmacology*
  • Animals
  • Calcium Channels / metabolism*
  • Cysteine Endopeptidases / metabolism*
  • Cysteine Proteinase Inhibitors / pharmacology
  • Dose-Response Relationship, Drug
  • Down-Regulation / drug effects*
  • Inositol 1,4,5-Trisphosphate / metabolism*
  • Inositol 1,4,5-Trisphosphate Receptors
  • Liver / drug effects
  • Liver / metabolism*
  • Multienzyme Complexes / metabolism*
  • Proteasome Endopeptidase Complex
  • Rats
  • Receptors, Cytoplasmic and Nuclear / metabolism*
  • Ubiquitins / metabolism

Substances

  • Calcium Channels
  • Cysteine Proteinase Inhibitors
  • Inositol 1,4,5-Trisphosphate Receptors
  • Multienzyme Complexes
  • Receptors, Cytoplasmic and Nuclear
  • Ubiquitins
  • Angiotensin II
  • lactacystin
  • Inositol 1,4,5-Trisphosphate
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex
  • Acetylcysteine